Biopharma

Opinion: The health policy cult’s misplaced faith in go...

If the past teaches us anything, it is that no one should expect the government ...

STAT+: Years after an Apple study, its tech has birthed...

Based on an Apple study, researchers have developed a free asthma management too...

Opinion: HHS’ national health security division must be...

The small but mighty Administration for Strategic Preparedness and Response at H...

STAT+: How much weight loss is too much? Pharma is push...

How much weight loss is too much? Pharma is pushing the limit with new obesity d...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Qaialdo, spironolacton...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Memantine Mylan, meman...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, D...

Boehringer’s Zongertinib Receives Priority Review from ...

Ridgefield, Conn., and Ingelheim, Germany, Feb. 19, 2025 -- Boehringer Ingelheim...

Clarity Receives US FDA Fast Track Designation for the ...

Sydney, Australia 19 February 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity”...

American Stroke Association, Feb. 5-7

The annual International Stroke Conference of the American Heart Association/Ame...

Flourish Research makes deal with Diablo to acquire the...

Clinical trial organization Flourish Research has made a deal with Diablo Clinic...

Fierce Biotech Layoff Tracker 2025: Moderna lays off 50...

As always, if you know of layoffs occurring at a biotech, please reach out to th...

It's curtain close for Spotlight: Gene editing biotech ...

CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendsch...

Cabaletta's CAR-T shows 'robust benefit' in lupus patie...

Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows...

Benzoyl Peroxide Formulation Characteristics Explain Va...

WEDNESDAY, Feb. 19, 2025 -- Formulation characteristics can explain much of the...

STAT+: Medical device lobby pushes back against Trump’s...

AdvaMed, the medical device lobby, pushed back Wednesday on the Trump administra...

Bristol Myers Squibb notches overall survival win with ...

Bristol Myers Squibb has bolstered its case for Opdivo to be used as a preoperat...

Ionis marks 'milestone event' of Tryngolza launch with ...

To support the launch of Tryngolza, which is approved to treat adults with famil...

UPDATE: RFK Jr. says HHS is 'bringing back common sense...

While the FDA’s diversity guidance for clinical trials has been temporarily rest...

Graduate student admissions paused and cut back as univ...

In response to Trump science policies, universities are accepting fewer graduate...

STAT+: Trump is giving Republicans a seemingly impossib...

It’s only possible to lower taxes without touching major government entitlement ...

Charles River lays off staffers at Memphis cell therapy...

Charles River Laboratories is continuing to downsize certain parts of its organi...

Deep Track nominates candidates for Dynavax's board, la...

After privately vying for a change to Dynavax’s corporate strategy for months, l...

Ionis marks ‘milestone event’ of Tryngolza launch with ...

To support the launch of Tryngolza, which is approved to treat adults with famil...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.